We are live on ! Find out more
CLB icon

Core Laboratories

302 hedge funds and large institutions have $6.37B invested in Core Laboratories in 2013 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 105 increasing their positions, 121 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

13% more funds holding in top 10

Funds holding in top 10: 89 (+1)

12% more capital invested

Capital invested by funds: $5.69B → $6.37B (+$678M)

4% more funds holding

Funds holding: 290302 (+12)

1% more call options, than puts

Call options by funds: $18.6M | Put options by funds: $18.4M

0.45% more ownership

Funds ownership: 81.91%82.36% (+0.45%)

13% less repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 121

Holders
302
Holders Change
+12
Holders Change %
+4.14%
% of All Funds
9.79%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.29%
New
33
Increased
105
Reduced
121
Closed
20
Calls
$18.6M
Puts
$18.4M
Net Calls
+$204K
Net Calls Change
+$6.43M
Name Holding Trade Value Shares
Change
Change in
Stake
IGIM
76
I.G. Investment Management
Manitoba, Canada
$10.3M -$1.27M -8,200 -12%
DIA
77
Denver Investment Advisors
Colorado
$10.3M +$5.45M +35,133 +138%
GA
78
Geneva Advisors
Illinois
$9.88M +$3.01M +19,409 +50%
Canada Pension Plan Investment Board
79
Canada Pension Plan Investment Board
Ontario, Canada
$9.8M +$8.99M +57,900 New
LWCFA
80
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$9.75M
VRS
81
Virginia Retirement Systems
Virginia
$9.72M -$700K -4,509 -7%
HIM
82
Hermes Investment Management
United Kingdom
$9.56M +$8.04M +51,820 +1,103%
Charles Schwab
83
Charles Schwab
California
$9.2M +$911K +5,869 +12%
BJ
84
BlackRock Japan
Japan
$9.09M -$176K -1,137 -2%
JP Morgan Chase
85
JP Morgan Chase
New York
$8.95M +$340K +2,191 +4%
CS
86
Credit Suisse
Switzerland
$8.74M -$2.81M -18,118 -26%
TCIM
87
TIAA CREF Investment Management
New York
$8.64M -$30.6M -196,920 -79%
Invesco
88
Invesco
Georgia
$8.48M -$2.97M -19,154 -28%
Franklin Resources
89
Franklin Resources
California
$8.48M +$15.5K +100 +0.2%
Swiss National Bank
90
Swiss National Bank
Switzerland
$8.43M +$93.1K +600 +1%
Capital Fund Management (CFM)
91
Capital Fund Management (CFM)
France
$8.13M -$5.13M -33,051 -41%
FIM
92
Friedberg Investment Management
Texas
$8.07M +$10.1K +65 +0.1%
AIM
93
Arcadia Investment Management
Michigan
$8.03M +$57.4K +370 +0.8%
Bank of Montreal
94
Bank of Montreal
Ontario, Canada
$7.9M -$1.15M -7,438 -14%
DT
95
Diversified Trust
Tennessee
$7.56M -$969K -6,245 -12%
WA
96
Westport Advisers
Connecticut
$6.77M
Allianz Asset Management
97
Allianz Asset Management
Germany
$6.64M -$69.1K -445 -1%
U
98
UBS
Switzerland
$6.5M +$1.13M +7,282 +23%
Axa
99
Axa
France
$6.31M -$5.17M -33,322 -47%
DBG
100
De Burlo Group
Massachusetts
$6.3M +$559K +3,600 +11%

CLB Hedge Fund Activity: Q3 2013 in Review

302 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2013, worth a combined $6.37B — up 12% from $5.69B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new CLB positions and 20 closed out — a net gain of 13 holders — while 105 added to existing stakes and 121 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $44.8M. The largest seller was Waddell & Reed Financial, cutting an estimated $34.3M.

  • 302 institutional investors held Core Laboratories (CLB) as of Q3 2013, up from 290 in Q2 2013.
  • Funds reported $6.37B of Core Laboratories stock for Q3 2013, up 12% quarter-over-quarter.
  • 33 funds opened new Core Laboratories positions in Q3 2013 and 20 closed out, a net change of +13 holders.
  • The largest Core Laboratories buyer in Q3 2013 was Janus Henderson Investors US, an estimated $44.8M added.
  • The largest Core Laboratories seller in Q3 2013 was Waddell & Reed Financial, an estimated $34.3M sold.

Based on aggregated 13F filings for Q3 2013.